Comparison of Recommendations for Screening Mammography Using CISNET Models

被引:79
作者
Arleo, Elizabeth Kagan [1 ]
Hendrick, R. Edward [2 ]
Helvie, Mark A. [3 ,4 ]
Sickles, Edward A. [5 ]
机构
[1] Weill Cornell Imaging New York Presbyterian, New York, NY USA
[2] Univ Colorado, Sch Med, Dept Radiol, Denver, CO USA
[3] Univ Michigan Hlth Syst, Dept Radiol, Ann Arbor, MI USA
[4] Univ Michigan Hlth Syst, Ctr Comprehens Canc, Ann Arbor, MI USA
[5] Univ Calif San Francisco, Dept Radiol, San Francisco, CA USA
基金
美国国家卫生研究院;
关键词
breast cancer; life-years gained; lives saved; mammography; mortality benefit; screening; BREAST-CANCER MORTALITY; BENEFITS; WOMEN; REDUCTION; UPDATE; HARMS; RISK;
D O I
10.1002/cncr.30842
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: Currently, there are several different recommendations for screening mammography from major national health care organizations, including: 1) annual screening at ages 40 to 84 years; 2) screening annually at ages 45 to 54 years, then biennially at ages 55 to 79 years; and 3) biennial screening at ages 50 to 74 years. METHODS: Mean values of six Cancer Intervention and Surveillance Modeling Network (CISNET) models were used to compare these three screening mammography recommendations in terms of benefits and risks. RESULTS: Mean mortality reduction was greatest with the recommendation of annual screening at ages 40 to 84 years (39.6%), compared with the hybrid recommendation of screening annually at ages 45 to 54 years, then biennially at ages 55 to 79 years (30.8%), and the recommendation of biennial screening at ages 50 to 74 years (23.2%). For a single-year cohort of US women aged 40 years, assuming 100% compliance, more breast cancers deaths would be averted over their lifetime with annual screening starting at age 40 (29,369) than with the hybrid recommendation (22,829) or biennial screening ages 50-74 (17,153 based on 2009 CISNET estimates, 15,599 based on 2016 CISNET estimates). To achieve the greatest mortality benefit, this single-year cohort of women would have the greatest total number of screening mammograms, benign recalls, and benign biopsies performed over the course of screening by following annual screening starting at age 40 years (90.2 million, 6.8 million, and 481,269, respectively) than by following the hybrid recommendation (49.0 million, 4.1 million, and 286,288, respectively) or biennial screening at ages 50 to 74 years (27.3 million, 2.3 million, and 162,885, respectively). CONCLUSION: CISNET models demonstrate that the greatest mortality reduction is achieved with annual screening of women starting at age 40 years. (C) 2017 American Cancer Society.
引用
收藏
页码:3673 / 3680
页数:8
相关论文
共 27 条
[1]  
[Anonymous], SEER CANC STAT REV 1
[2]  
[Anonymous], J NATL CANC I
[3]  
[Anonymous], 2012 BIENN SURV C BE
[4]   The impact of mammographic screening on breast cancer mortality in Europe: a review of observational studies [J].
Broeders, Mireille ;
Moss, Sue ;
Nystrom, Lennarth ;
Njor, Sisse ;
Jonsson, Hakan ;
Poop, Ellen ;
Massat, Nathalie ;
Duffy, Stephen ;
Lynge, Elsebeth ;
Paci, Eugenio .
JOURNAL OF MEDICAL SCREENING, 2012, 19 :14-25
[5]   Screening for Breast Cancer: US Preventive Services Task Force Recommendation Statement [J].
Calonge, Ned ;
Petitti, Diana B. ;
DeWitt, Thomas G. ;
Dietrich, Allen J. ;
Gregory, Kimberly D. ;
Grossman, David ;
Isham, George ;
LeFevre, Michael L. ;
Leipzig, Rosanne M. ;
Marion, Lucy N. ;
Melnyk, Bernadette ;
Moyer, Virginia A. ;
Ockene, Judith K. ;
Sawaya, George F. ;
Schwartz, J. Sanford ;
Wilt, Timothy .
ANNALS OF INTERNAL MEDICINE, 2009, 151 (10) :716-W236
[6]   Pan-Canadian Study of Mammography Screening and Mortality from Breast Cancer (vol 106, dju261, 2014) [J].
Coldman, Andrew ;
Phillips, Norm ;
Wilson, Christine ;
Decker, Kathleen ;
Chiarelli, Anna M. ;
Brisson, Jacques ;
Zhang, Bin ;
Payne, Jennifer ;
Doyle, Gregory ;
Ahmad, Rukshanda .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2015, 107 (01)
[7]   Effectiveness of Population-Based Service Screening With Mammography for Women Ages 40 to 49 Years Evaluation of the Swedish Mammography Screening in Young Women (SCRY) Cohort [J].
Hellquist, Barbro Numan ;
Duffy, Stephen W. ;
Abdsaleh, Shahin ;
Bjorneld, Lena ;
Bordas, Pal ;
Tabar, Laszlo ;
Vitak, Bedrich ;
Zackrisson, Sophia ;
Nystrom, Lennarth ;
Jonsson, Hakan .
CANCER, 2011, 117 (04) :714-722
[8]   Breast cancer mortality in participants of the Norwegian Breast Cancer Screening Program [J].
Hofvind, Solveig ;
Ursin, Giske ;
Tretli, Steinar ;
Sebuodegard, Sofie ;
Moller, Bjorn .
CANCER, 2013, 119 (17) :3106-3112
[9]   Collaborative Modeling of the Benefits and Harms Associated With Different US Breast Cancer Screening Strategies [J].
Mandelblatt, Jeanne S. ;
Stout, Natasha K. ;
Schechter, Clyde B. ;
van den Broek, Jeroen J. ;
Miglioretti, Diana L. ;
Krapcho, Martin ;
Trentham-Dietz, Amy ;
Munoz, Diego ;
Lee, Sandra J. ;
Berry, Donald A. ;
van Ravesteyn, Nicolien T. ;
Alagoz, Oguzhan ;
Kerlikowske, Karla ;
Tosteson, Anna N. A. ;
Near, Aimee M. ;
Hoeffken, Amanda ;
Chang, Yaojen ;
Heijnsdijk, Eveline A. ;
Chisholm, Gary ;
Huang, Xuelin ;
Huang, Hui ;
Ergun, Mehmet Ali ;
Gangnon, Ronald ;
Sprague, Brian L. ;
Plevritis, Sylvia ;
Feuer, Eric ;
de Koning, Harry J. ;
Cronin, Kathleen A. .
ANNALS OF INTERNAL MEDICINE, 2016, 164 (04) :215-+
[10]   Effects of Mammography Screening Under Different Screening Schedules: Model Estimates of Potential Benefits and Harms [J].
Mandelblatt, Jeanne S. ;
Cronin, Kathleen A. ;
Bailey, Stephanie ;
Berry, Donald A. ;
de Koning, Harry J. ;
Draisma, Gerrit ;
Huang, Hui ;
Lee, Sandra J. ;
Munsell, Mark ;
Plevritis, Sylvia K. ;
Ravdin, Peter ;
Schechter, Clyde B. ;
Sigal, Bronislava ;
Stoto, Michael A. ;
Stout, Natasha K. ;
van Ravesteyn, Nicolien T. ;
Venier, John ;
Zelen, Marvin ;
Feuer, Eric J. .
ANNALS OF INTERNAL MEDICINE, 2009, 151 (10) :738-W247